HEMERUS
LIVE

Serial Number

98148105

Owner

Hemerus Medical LLC

Attorney

Nancy Wilker

First Use Date

May 14, 2024

Filing Date

Aug 24, 2023

Add to watchlist:

No watchlists yet
View on USPTO

HEMERUS Trademark

Serial Number: 98148105 • Registration: 8024312

HEMERUS is a trademark filed by Hemerus Medical LLC on August 24, 2023. The trademark is classified under Class 1 (Chemicals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Hemerus Medical LLC (9 trademarks)

5000 Township Parkway
St. Paul, MN 55110

Entity Type: 16

Trademark Details

Filing Date

August 24, 2023

Registration Date

November 11, 2025

First Use Anywhere

May 14, 2024

First Use in Commerce

May 14, 2024

Published for Opposition

July 23, 2024

Goods & Services

Chemical preparations for scientific purposes, namely, chemical solutions used to aid in the anticoagulation, preservation, or storage of whole blood and cellular and non-cellular blood products, in particular plasma, platelets, and red blood cells for scientific and laboratory purposes; chemical preparations for the manufacture of tubing, bags, and filters for collecting or storing whole blood and cellular and non-cellular blood products, in particular plasma, platelets, white blood cells, plasma proteins in the nature of immunoglobulins, and red blood cells

Medical devices, namely, kits for the collection, preservation, or storage of whole blood and cellular and non-cellular blood products, in particular plasma, platelets, white blood cells, and red blood cells, comprised of medical tubing for transfusions, empty blood storage bags, and medical whole blood and cellular and non-cellular blood products, in particular plasma, platelets, plasma proteins in the nature of immunoglobulins, and red blood cells, as well as anticoagulation and chemical storage solutions; filters for blood and blood components for medical use, namely, filters for reducing leukocytes and white blood cells in collected whole blood, and cellular and non-cellular blood products, in particular plasma, platelets, and red blood cells

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 17, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 17, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2025 CRFA
ASSIGNED TO LIE
Oct 16, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 9, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 8, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 8, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 15, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 15, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 15, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Mar 25, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 25, 2025 AITU
USE AMENDMENT FILED
Jan 17, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 17, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 17, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 18, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 18, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 18, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 18, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 18, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 22, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 22, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 22, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 19, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 24, 2023 NWOS
NEW APPLICATION ENTERED
Aug 28, 2023 NWAP